I choose to believe that the head office (SM) is maximizing their technology in order to make bankruptcy an impossibility. There's just too many positives for this to "run out of money". Am I a fool to think this? Maybe....$SGMO
$SGMO is generic and uninteresting in that it's a small, low market cap biotech company like any other.
What's unique is that it has stood the test of time for 30 years....⬇️
Week after week we see nothing but best-in-class data. While others produce underwhelming results and temporary solutions, $SGMO continues to show promising research that out paces the competition. ⬇️
@fabre_de Why can't they just say "join our CEO, SM for a fireside chat where he actually announces the Fabry deal he's been teasing and delaying for months and months"